INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

A modified procedure for percutaneous pulmonary valve implantation of the Edwards SAPIEN 3 valve

EuroIntervention 2019;14:1386-1388 published online October 2018. DOI: 10.4244/EIJ-D-18-00530

Sébastien Hascoet1*, MD; Clément Karsenty2, MD; Marine Tortigue1, MD; A. Claire Watkins1,3, MD; Jean-Yves Riou1, MD; Angèle Boet1, MD; Nabil Tahhan1, MD; Dominique Fabre1, MD, PhD; Stephan Haulon1, MD, PhD; Philippe Brenot1, MD; Jérôme Petit1, MD

1. Hôpital Marie Lannelongue, Le Plessis-Robinson, France; 2. Hôpital des Enfants, Toulouse, France; 3. Stanford University School of Medicine, Stanford, CA, USA

Percutaneous pulmonary valve implantation (PPVI) with SAPIEN valves offers promising results, but it remains technically challenging1,2. The valve is introduced into a short sheath and advanced uncovered to the right ventricular outflow tract (RVOT). Tricuspid valve injury has been reported during this manoeuvre3. We describe a protective delivery method of the SAPIEN 3 valve (S3; Edwards Lifesciences, Irvine, CA, USA) in the pulmonary position.

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Interventions for valvular diseaseInterventions for heart failureTricuspid / Pulmonary valveChronic heart failure

Share on Facebook Share on Twitter Share on Linkedin